In brief
McKinsey & Co. has struck a deal to pay more than $122 million after being implicated in a bribery probe related to its consulting assignments in South Africa. This agreement, revealed by New York federal prosecutors, is part of a deferred prosecution arrangement that could lead to the dismissal of the bribery charge in three years, contingent on the company's compliance. A former senior partner, Vikas Sagar, has pleaded guilty to conspiracy charges tied to these allegations. The investigation pointed to improper dealings that earned McKinsey vast profits by obtaining lucrative contracts in exchange for bribing officials at state-owned entities. This marks a considerable chapter in McKinsey's ongoing legal woes, which include a $1 billion payout connected to the opioid crisis.
In what marks a significant legal outcome, McKinsey & Co. has consented to pay over $122 million in fines linked to a felony bribery investigation related to its work in South Africa. According to an unsealed court filing by federal prosecutors in New York, this comes in addition to previous settlements wherein the consultancy has faced penalties totaling around $1 billion for various legal infractions, including its alleged involvement with opioid manufacturers. Under the recently established deferred prosecution agreement, McKinsey's bribery charge could be dismissed within three years if the firm adheres to stipulated conditions.The investigation revealed that McKinsey's South African operations had engaged in bribery to secure consulting contracts with two key government-owned entities responsible for managing South Africa's electric and freight rail systems. Vikas Sagar, a former senior partner who led the Johannesburg office, is among the individuals who have confessed to misconduct, having received sensitive data that led to these agreements. The overall scheme reportedly allowed McKinsey to covertly direct funds to government officials, resulting in profits amounting to $85 million.The company's actions in South Africa were deemed its most consequential blunder in nearly a century, dating back over ten years. The scrutiny intensified following revelations of McKinsey's role in assisting Purdue Pharma during the opioid crisis. As these investigations unfold, McKinsey continues to navigate significant legal challenges related to both the bribery allegations and its controversial work advising opioid manufacturers.
